TAKP34:BVMF
Takeda Pharmaceutical Co Ltd BDR
90,54 BRL
0,00%
(0,00) 1D
6-окт., 15:21:39 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TAKP34...
Mkt. cap
58,99 млд
Avg. vol.
36,00
Volume
0,00
52-wk high
102,65 BRL
52-wk low
70,80 BRL
Shares outstanding
1,60 млд
No. of employees
47 миң
Mkt. cap
58,99 млд
Avg. vol.
36,00
Volume
0,00
52-wk high
102,65 BRL
52-wk low
70,80 BRL
Shares outstanding
1,60 млд
No. of employees
47 миң
News stories
From web sources and news partners
AD HOC NEWS
·
38 мүнөт мурун
Takeda Pharmaceutical stock after-hours at EUR 16.55: quote at 8:08 p.m. CEST from Lang & Schwarz
Simply Wall Street
·
23 саат мурун
Should Phase 3 Psoriasis Win Require Action From Takeda Stock Investors?
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd BDR
CEOChristophe Weber | Christophe Weber
Employees47 миң
Founded1781-ж., 12-июн.
Headquarters-
SectorPharmaceutical industry
Websitetakeda.com